Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandra Arvanitaki

Showing results (71-80 of 77) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 77 results.
International Journal of Cardiology|December 11, 2024
Survival prospects of pulmonary arterial hypertension associated with congenital heart disease: Insights from the HOPE registryVasiliki Patsiou, Alexandra Arvanitaki, Ioannis T Farmakis, et al.
Chest|August 25, 2024
Association of Phosphodiesterase-5 Inhibitor Treatment With Improved Survival in Pulmonary Hypertension Associated With COPD in the Pulmonary Vascular Research Institute GoDeep Meta-RegistryKhodr Tello, Athiththan Yogeswaran, Raphael W Majeed, et al.
Journal of Clinical Medicine|October 13, 2021
Epidemiology and Management of Chronic Thromboembolic Pulmonary Hypertension in Greece. Real-World Data from the Hellenic Pulmonary Hypertension Registry (HOPE)Eftychia Demerouti, Panagiotis Karyofyllis, Vassilios Voudris, et al.
Pulmonary Circulation|July 10, 2025
Survival Outcomes and Impact of Targeted PAH Therapy in Portopulmonary Hypertension in the PVRI GoDeep Meta-RegistryArun Jose, Athiththan Yogeswaran, Meike Fuenderich, et al.
Chest|March 20, 2024
Comparison of Contemporary Risk Scores in All Groups of Pulmonary Hypertension: A Pulmonary Vascular Research Institute GoDeep Meta-Registry AnalysisAthiththan Yogeswaran, Henning Gall, Meike Fünderich, et al.
American Journal of Respiratory and Critical Care Medicine|August 7, 2025
Hemodynamics and Phosphodiesterase-5 Inhibitor Treatment Associated with Survival in ILD-PH: A PVRI GoDeep Meta-Registry AnalysisAthiththan Yogeswaran, Paul M Hassoun, Khaled Saleh, et al.
Ebiomedicine|December 17, 2025
Male survival disadvantage in pulmonary hypertension: independent of aetiology, age, disease severity, comorbidities and treatmentAthiththan Yogeswaran, Jeffrey S Annis, Meike Fünderich, et al.
Pageof 8

Showing results (71-80 of 77) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
International Journal of Cardiology|December 11, 2024
Survival prospects of pulmonary arterial hypertension associated with congenital heart disease: Insights from the HOPE registryVasiliki Patsiou, Alexandra Arvanitaki, Ioannis T Farmakis, et al.
Chest|August 25, 2024
Association of Phosphodiesterase-5 Inhibitor Treatment With Improved Survival in Pulmonary Hypertension Associated With COPD in the Pulmonary Vascular Research Institute GoDeep Meta-RegistryKhodr Tello, Athiththan Yogeswaran, Raphael W Majeed, et al.
Journal of Clinical Medicine|October 13, 2021
Epidemiology and Management of Chronic Thromboembolic Pulmonary Hypertension in Greece. Real-World Data from the Hellenic Pulmonary Hypertension Registry (HOPE)Eftychia Demerouti, Panagiotis Karyofyllis, Vassilios Voudris, et al.
Pulmonary Circulation|July 10, 2025
Survival Outcomes and Impact of Targeted PAH Therapy in Portopulmonary Hypertension in the PVRI GoDeep Meta-RegistryArun Jose, Athiththan Yogeswaran, Meike Fuenderich, et al.
Chest|March 20, 2024
Comparison of Contemporary Risk Scores in All Groups of Pulmonary Hypertension: A Pulmonary Vascular Research Institute GoDeep Meta-Registry AnalysisAthiththan Yogeswaran, Henning Gall, Meike Fünderich, et al.
American Journal of Respiratory and Critical Care Medicine|August 7, 2025
Hemodynamics and Phosphodiesterase-5 Inhibitor Treatment Associated with Survival in ILD-PH: A PVRI GoDeep Meta-Registry AnalysisAthiththan Yogeswaran, Paul M Hassoun, Khaled Saleh, et al.
Ebiomedicine|December 17, 2025
Male survival disadvantage in pulmonary hypertension: independent of aetiology, age, disease severity, comorbidities and treatmentAthiththan Yogeswaran, Jeffrey S Annis, Meike Fünderich, et al.
Pageof 8